文献速递神经肿瘤

342例老年胶质母细胞瘤患者十年手术治疗经验:我们学到了什么

One decade of glioblastoma multiforme surgery in 342 elderly patients: what have we learned?
PubMed 文献 · J Neurooncol · 2018-08-03

该研究回顾性分析342例≥65岁胶质母细胞瘤患者的手术治疗、辅助治疗、总生存期及功能结局。中位总生存期7.5个月,全切除者中位总生存期显著高于部分切除和活检者(10.8个月)。接受联合放化疗者总生存期显著更长,尤其MGMT阴性者。结论认为全切除和辅助联合放化疗使老年患者总生存期获益,治疗决策应基于术前功能状态而非生物学年龄。

要点

  • 老年胶质母细胞瘤患者中位总生存期为7.5个月(95%CI 6.0-9.1)。
  • 全切除者中位总生存期显著高于部分切除和活检者(10.8个月;95%CI 9.5-12.3)。
  • 联合放化疗者总生存期显著更长,尤其MGMT阴性者;术前KPS越高总生存期越好。

核心结论

  • 全切除和辅助联合放化疗使老年胶质母细胞瘤患者总生存期获益。
  • 治疗决策应基于术前功能状态而非生物学年龄。

研究设计与样本

  • 回顾性分析342例年龄≥65岁的老年胶质母细胞瘤患者,于本神经外科中心接受治疗。
  • 分析手术方式、辅助治疗、总生存期及基于KPS和神经肿瘤学神经评估评分的功能结局。

主要发现

  • 诊断时中位年龄73.4岁(IQR 9.28)。
  • 中位总生存期7.5个月(95%CI 6.0-9.1),术前或术后中位KPS为80(IQR 20)。
  • 216例(63.2%)行手术切除,125例(36.5%)行立体定向活检。
  • 全切除者中位总生存期显著高于部分切除和活检者(10.8个月;95%CI 9.5-12.3)。
  • 接受联合放化疗者总生存期显著更长,尤其MGMT阴性胶质母细胞瘤;术前KPS更高与总生存期改善相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Glioblastoma multiforme (GBM) is the most common malignant primary brain tumor in adults with peak incidence in patients older than 65 years. These patients are mostly underrepresented in clinical trials and often undertreated due to concomitant diseases. Recently, different therapeutic approaches for elderly patients with GBM were discussed. To date, there is no defined standard treatment. The aim of the present study is to evaluate the functional and oncological outcome in surgical treatment of elderly patients. MATERIALS AND METHODS: A total of 342 elderly patients aged ≥ 65 years were retrospectively analyzed in our neurosurgical center. Surgical therapy, adjuvant treatment, overall survival (OS) and functional outcome using Karnofsky performance scale (KPS) and Neurological assessment of neuro-oncology-score were analyzed. RESULTS: The median age at GBM diagnosis was 73.4 (IQR 9.28) years. Median overall survival was 7.5 (CI 95% 6.0-9.1) months and median preoperative or postoperative KPS was 80 (IQR 20). Surgical resection was performed in 216 (63.2%) patients, in 125 patients (36.5%) patients a stereotactic biopsy was performed. The median OS was significantly higher in patients with gross total resection (GTR) compared to partial resection and biopsy (10.8 months; CI 95% 9.5-12.3). Patients with combined radio- and chemo-therapy (RCT) showed significant longer OS, particularly MGMT-negative GBM. Higher preoperative KPS was found to be associated with improved overall survival. CONCLUSION: GTR and adjuvant combined RCT provides benefits for overall survival in elderly patients. Therapy decision should be made in regard to preoperative functional status instead of biological age.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Heiland DH, Haaker G, Watzlawick R, et al. One decade of glioblastoma multiforme surgery in 342 elderly patients: what have we learned? J Neurooncol. 2018. PMID: 30076585. doi:10.1007/s11060-018-2964-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。